New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities |
| |
Authors: | Feenstra R W de Moes J Hofma J J Kling H Kuipers W Long S K Tulp M T van der Heyden J A Kruse C G |
| |
Affiliation: | Solvay Pharmaceuticals, Research Laboratories, PO Box 900, 1380 DA, Weesp, The Netherlands. rolf.feenstra@solvay.com |
| |
Abstract: | ![](https://cache.aipub.cn/cache?img_url=https://ars.els-cdn.com/content/image/1-s2.0-S0960894X01004255-fx5221.gif) This paper describes the syntheses of several 1-aryl-4-(biarylmethylene)piperazines and the results of the determination of their affinity for D(2) and 5-HT(1A) receptors. A selection of these compounds was evaluated in vivo, resulting in the identification of a drug candidate which is being clinically evaluated as a potential atypical antipsychotic with reduced extrapyrimidal side effects. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |